Microsensor Arrays for Saliva Diagnostics
用于唾液诊断的微传感器阵列
基本信息
- 批准号:7282485
- 负责人:
- 金额:$ 173.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAccident and Emergency departmentAcuteAcute PneumoniaAmbulatory Care FacilitiesBiological AssayBostonChronic Obstructive Airway DiseaseChronic Obstructive AsthmaClinicClinicalClinical InvestigatorClinical ResearchCollectionComplexConditionCystic FibrosisDataDevicesDiagnosisDiagnosticDiseaseDocumentationElectronicsFilmGoalsHuman ResourcesIonsLaboratoriesLeadLightLiquid substanceLungLung diseasesMeasuresMicrofluidic MicrochipsMicrofluidicsNumbersOperative Surgical ProceduresOptical ReadersOpticsOutcomePartner in relationshipPatientsPennsylvaniaPerformancePersonal SatisfactionPhasePilot ProjectsPolymerasePolymerase Chain ReactionPositioning AttributePreparationProcessProteinsPulmonary EmphysemaRNA-Directed DNA PolymeraseReaderReadingReagentReportingResearch PersonnelSalesSalivaSalivarySamplingSolutionsSourceSpecimenStagingSystemTestingTherapeuticTrainingUniversitiesWireless Technologybaseclinically relevantcytokinedesigndesign and constructionfield studyliquid crystaloptical fiberoral biologyprogramsprototyperespiratorysaliva diagnosticsensorsmall molecule
项目摘要
DESCRIPTION (provided by applicant): This application aims to develop a portable, diagnostic system useable by minimally trained personnel in the field for the diagnosis of pulmonary diseases using saliva as a sample specimen. The ultimate goal of the project is to create a universal platform for performing systemic diagnosis using saliva. The device will be fully integrated and self-contained. A saliva specimen will be loaded onto a disposable microfluidic card containing all the necessary components and reagents to process the sample and measure multiple clinically relevant analytes with an optical fiber microarray. The results will be read optically and reported both via a liquid crystal display and over a wireless network. Pulmonary diseases will be targeted including asthma, chronic obstructive pulmonary disease (COPD)/emphysema, cystic fibrosis, and acute pneumonia. Saliva samples from both diseased and control patients will be obtained and analyzed using a variety of fluorescent-based assays. The initial phase will be carried out in an outpatient clinic setting, where patients will be followed at regular intervals when stable and during exacerbations of their disease. Samples will be collected and analyzed at baseline and during clinically unstable conditions allowing analysis of change from baseline as well as single sample correlations with clinical status. To directly test our overall hypothesis that saliva contains substances that correlate with disease, we will also collect and analyze key representative respiratory secretions and compare these results with those obtained from salivary analysis. Analytes that correlate with disease will be selected and converted into bead-based sensors for use with optical fiber microarrays. Analytes to be examined will include DNA/RNA, proteins such as cytokines, and small molecules and ions. All sample preparation and pre-treatments will be incorporated onto a microfluidic cassette. The disposable cassette will be integrated with the sensor array, enabling many clinical parameters to be measured simultaneously. The array will be interrogated by a portable optical reader that will be designed and integrated with the microfluidic cassette and the optical fiber array. We will demonstrate efficacy of the system at the lab bench and later provide one Alpha and three Beta units to the clinical investigators for pilot studies and expanded field trials.
描述(由申请人提供):本申请旨在开发一种便携式诊断系统,可由该领域经过最低限度培训的人员使用,以唾液作为样本样本诊断肺部疾病。该项目的最终目标是创建一个使用唾液进行系统诊断的通用平台。该设备将是完全集成且独立的。唾液样本将被加载到一次性微流体卡上,该卡包含处理样本和使用光纤微阵列测量多种临床相关分析物所需的所有组件和试剂。结果将以光学方式读取并通过液晶显示器和无线网络报告。肺部疾病将成为治疗目标,包括哮喘、慢性阻塞性肺病(COPD)/肺气肿、囊性纤维化和急性肺炎。将使用各种基于荧光的检测方法获取并分析患病患者和对照患者的唾液样本。初始阶段将在门诊诊所进行,在病情稳定和病情恶化期间,将定期对患者进行随访。将在基线和临床不稳定条件下收集和分析样本,以便分析基线的变化以及单个样本与临床状态的相关性。为了直接检验我们的总体假设,即唾液中含有与疾病相关的物质,我们还将收集和分析关键的代表性呼吸道分泌物,并将这些结果与唾液分析获得的结果进行比较。与疾病相关的分析物将被选择并转化为基于珠子的传感器,以与光纤微阵列一起使用。待检查的分析物包括 DNA/RNA、细胞因子等蛋白质以及小分子和离子。所有样品制备和预处理都将纳入微流体盒中。一次性盒将与传感器阵列集成,从而能够同时测量许多临床参数。该阵列将由便携式光学读取器进行询问,该读取器将与微流体盒和光纤阵列设计并集成。我们将在实验室工作台上展示该系统的功效,然后向临床研究人员提供一个 Alpha 和三个 Beta 装置,用于试点研究和扩大的现场试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID R. WALT其他文献
DAVID R. WALT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID R. WALT', 18)}}的其他基金
Simplified Single Molecule Protein Assays with Unprecedented Sensitivity
简化的单分子蛋白质检测,具有前所未有的灵敏度
- 批准号:
10657044 - 财政年份:2023
- 资助金额:
$ 173.68万 - 项目类别:
Simplified Single Molecule Protein Assays with Unprecedented Sensitivity
简化的单分子蛋白质检测,具有前所未有的灵敏度
- 批准号:
10644163 - 财政年份:2022
- 资助金额:
$ 173.68万 - 项目类别:
Detection of Post-Translationally Modified Proteins as a Biomarker Panel for Parkinson's Disease
检测翻译后修饰蛋白作为帕金森病的生物标志物组
- 批准号:
9607157 - 财政年份:2016
- 资助金额:
$ 173.68万 - 项目类别:
Bioinformatics Inquiry through Sequencing (BIOSEQ)
通过测序进行生物信息学查询(BIOSEQ)
- 批准号:
8289763 - 财政年份:2012
- 资助金额:
$ 173.68万 - 项目类别:
Bioinformatics Inquiry through Sequencing (BIOSEQ)
通过测序进行生物信息学查询(BIOSEQ)
- 批准号:
8877366 - 财政年份:2012
- 资助金额:
$ 173.68万 - 项目类别:
Bioinformatics Inquiry through Sequencing (BIOSEQ)
通过测序进行生物信息学查询(BIOSEQ)
- 批准号:
8478223 - 财政年份:2012
- 资助金额:
$ 173.68万 - 项目类别:
Bioinformatics Inquiry through Sequencing (BIOSEQ)
通过测序进行生物信息学查询(BIOSEQ)
- 批准号:
8676956 - 财政年份:2012
- 资助金额:
$ 173.68万 - 项目类别:
Development of new tools for Single Cell Analysis
开发单细胞分析新工具
- 批准号:
8022525 - 财政年份:2010
- 资助金额:
$ 173.68万 - 项目类别:
Development of new tools for Single Cell Analysis
开发单细胞分析新工具
- 批准号:
8197062 - 财政年份:2010
- 资助金额:
$ 173.68万 - 项目类别:
Development of new tools for Single Cell Analysis
开发单细胞分析新工具
- 批准号:
8423040 - 财政年份:2010
- 资助金额:
$ 173.68万 - 项目类别:
相似海外基金
Mixed methods examination of warning signs within 24 hours of suicide attempt in hospitalized adults
住院成人自杀未遂 24 小时内警告信号的混合方法检查
- 批准号:
10710712 - 财政年份:2023
- 资助金额:
$ 173.68万 - 项目类别:
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
- 批准号:
10749448 - 财政年份:2023
- 资助金额:
$ 173.68万 - 项目类别:
Clinical effectiveness of a wearable hydration device
可穿戴水化装置的临床效果
- 批准号:
10773374 - 财政年份:2022
- 资助金额:
$ 173.68万 - 项目类别:
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications, and CBT4CBT: A randomized clinical trial in a diverse patient population
通过简短干预、药物和 CBT4CBT 促进住院后酒精治疗的参与:针对不同患者群体的随机临床试验
- 批准号:
10491299 - 财政年份:2021
- 资助金额:
$ 173.68万 - 项目类别:
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications, and CBT4CBT: A randomized clinical trial in a diverse patient population
通过简短干预、药物和 CBT4CBT 促进住院后酒精治疗的参与:针对不同患者群体的随机临床试验
- 批准号:
10629406 - 财政年份:2021
- 资助金额:
$ 173.68万 - 项目类别: